Some Wall Street investors expect Gilead to come in at $4,000 per patient or higher to make a profit above its coronavirus drug's development cost
) faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
That backlash has subsided considerably in the midst of the coronavirus pandemic, during which drugmakers’ efforts to develop vaccines and treatments is considered essential to battling a disease that has infected some 3.7 million people and killed over 258,000 worldwide. Gilead Chief Executive Daniel O’Day, in the post just over a year, is proceeding with caution. The company is donating enough remdesivir for at least 140,000 patients for distribution by the U.S. government to hospitals nationally.
The Institute for Clinical and Economic Review , which assesses effectiveness of drugs to determine appropriate prices, suggested a maximum price of $4,500 per 10-day treatment course based on the preliminary evidence of how much patients benefited in a clinical trial. Consumer advocacy group Public Citizen on Monday said remdesivir should be priced at $1 per day of treatment, since “that is more than the cost of manufacturing at scale with a reasonable profit to Gilead.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Who can make Gilead's coronavirus drug, licence free?Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.
Read more »
Pandemic fallout is severely threatening US dairy farmsDairy farmers have to figure out what to do with their extremely perishable product, when about half of the industry’s demand from restaurants, school cafeterias, and other food service is cut off.
Read more »
The Coming COVID-19 Higher Ed DisasterPublic colleges and universities became a lot less “public” after the Great Recession. The coronavirus crisis could make it all a lot worse. ed_kilgore on the coming disaster for higher education
Read more »
Have mixed messages on masks, a critical tool to slow pandemic, slowed widespread adoption?Public health experts agree that the continued wearing of masks and other face-coverings in public will be a critical tool in slowing the spread of the novel coronavirus.
Read more »
General Motors ekes out $294 million profit in the first quarter despite coronavirus pandemic crippling production and salesGeneral Motors eked out a $294 million profit for the first quarter despite the fall out from the coronavirus pandemic that's shuttered factories and devastated sales.
Read more »
Wendy's net income falls 55% as coronavirus weighs on profits
Read more »